GLP-1 medications typically achieve this threshold within 8 to 12 weeks, though individual timelines vary
Parallelly, we also retrieved the MI-related targets from the five databases, and 727 targets were identified, including 313 from the GeneCards database, 18 from the OMIM database, 121 from the PharmGkb database, 47 from the TTD database, and 133 from the DrugBank database
According to the FDA prescribing information, tirzepatide is associated with modest increases in heart rate (average 2-4 beats per minute), consistent with the class effect observed with GLP-1 receptor agonists
Cancer diagnosis was confirmed when both the ICD-10 codes (C00C97) and cancer-specific insurance claims codes (V codes) were met
The compound's natural origin in protective gastric secretions aligns with its documented tissue-protective and healing-promoting properties
The following references were used to support key facts on this page